CHME OTC
China Medicine Corp.
1W: -21.3%
1M: -52.1%
3M: +51.2%
YTD: -4.6%
1Y: +2483.3%
3Y: +30900.0%
5Y: +55.0%
$0.03
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$65M
+20.7% ▲
5Y CAGR: +44.2%
Gross Profit
$19M
+21.9% ▲
5Y CAGR: +42.4%
Operating Income
$12M
+12.2% ▲
5Y CAGR: +38.4%
Net Income
$2M
-81.2% ▼
5Y CAGR: -10.2%
EPS (Diluted)
$0.11
-81.7% ▼
5Y CAGR: -22.4%
EBITDA
$13M
+17.0% ▲
5Y CAGR: +39.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 |
|---|---|---|---|---|---|
| Revenue | $0 | $24M | $42M | $54M | $65M |
| YoY Growth | -100.0% | +0.0% | +75.5% | +27.4% | +20.7% |
| Cost of Revenue | $0 | $15M | $30M | $38M | $46M |
| Gross Profit | $0 | $9M | $12M | $16M | $19M |
| Gross Margin | — | 37.4% | 29.4% | 29.0% | 29.3% |
| R&D Expenses | $0 | $294K | $652K | $840K | $1M |
| SG&A Expenses | $32K | $2M | $3M | $4M | $5M |
| Operating Expenses | $32K | $3M | $4M | $5M | $7M |
| Operating Income | -$32K | $6M | $8M | $11M | $12M |
| Operating Margin | — | 25.8% | 20.0% | 20.4% | 18.9% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $0 | $6M | $8M | $11M | $5M |
| Tax Expense | $32K | $1M | $2M | $2M | $4M |
| Net Income | -$32K | $5M | $7M | $9M | $2M |
| Net Margin | — | 20.0% | 16.3% | 17.0% | 2.7% |
| EPS (Diluted) | $-0.01 | $0.63 | $0.50 | $0.60 | $0.11 |
| EBITDA | -$32K | $6M | $9M | $11M | $13M |
| Shares Outstanding | 7M | 8M | 14M | 15M | 15M |